Bringing AI into GxP Operations — Real-World Execution
This LinkedIn Live session explored practical AI adoption across GxP-regulated IT, quality, and manufacturing, focusing on real-world execution while maintaining compliance and inspection readiness.
Speakers discussed how AI-driven analytics, automation, and intelligent agents are being applied within regulated operations to enhance quality processes and compliance workflows. The conversation emphasized that clearly defined intended use, strong governance, and ongoing human oversight are critical to scaling AI without compromising regulatory expectations.
The session highlighted measurable outcomes from AI adoption across regulated environments, including faster validation and documentation workflows, improved audit and inspection readiness through enhanced traceability, and more effective batch review, deviation analysis, and risk-based decision-making. The discussion reinforced AI’s role as a co-pilot—supporting human judgment while strengthening GxP compliance.
Event at a Glance
Key metrices from our successful webinar session
624+
Registartions
390+
Unique Viewers
3536
Minutes viewed
Featured Voices
Visionaries who led the conversation.
Bob Buhlmann
Head of Quality, Digital & Computer Strategy, AstraZeneca
Nagesh Nama
Chief Executive Officer, xLM
45 Minutes of
Practical Insight
January 29, 2026
Full access session recording available on demand.
45 Minutes of Content
Recorded LinkedIn Live session sharing practical AI adoption insights for GxP-regulated environments.
This LinkedIn Live session brought together industry leaders to explore how Artificial Intelligence is being practically applied across pharma IT, quality, and manufacturing operations within GxP-regulated environments. The discussion moved beyond AI hype to focus on real execution—covering validation, governance, inspection readiness, and human oversight. Speakers shared hands-on insights into how AI-driven analytics, automation, and intelligent agents can enhance compliance workflows, improve decision-making, and deliver measurable operational value while meeting regulatory expectations.
Detailed Event Overview
The LinkedIn Live event “GxP in the Age of AI — Real-World Perspectives from Pharma IT & Manufacturing” explored how life sciences organizations are practically adopting Artificial Intelligence within GxP-regulated environments. The session focused on moving beyond experimental use cases to real-world execution—showcasing how AI supports quality systems, manufacturing operations, and compliance workflows while remaining inspection-ready and aligned with regulatory expectations.
AI in GxP Insights
The discussion featured industry leaders sharing hands-on experiences with AI adoption across regulated pharma environments. The conversation emphasized governance, intended use, and human oversight as critical enablers of successful AI deployment in GxP. Key discussion points included:
- Why AI is no longer experimental in regulated life sciences environments
- Defining and controlling intended use for AI-enabled systems
- Addressing validation challenges and common “black-box” misconceptions
- How AI assists with documentation, batch review, deviation analysis, and risk assessment
- Ensuring explainability, traceability, and audit readiness for inspections
A Glance at Our Online Event
Couldn't make it in person? Our hybrid model ensured that thousands joined us virtually. Experience the high-fidelity stream that brought the summit to living rooms worldwide.
Ready to Elevate Your Operations?
Don't let the momentum stop here. Leverage our expert consulting services to implement the strategies discussed at the summit and drive your business forward.